TYKSLAB LAB

Julkaisut 2014
Publications 2014

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aarnio EJ et al. Register-based predictors of adherence among new statin users in Finland.
2 Arponen E et al. A PET tracer for brain alpha 2C Adrenoceptors, 11C-ORM-13070: Radiosynthesis and preclinical evaluation in rats and knockout mice.
3 Baldock PA et al. Neuropeptide Y attenuates stress-induced bone loss through suppression of noradrenaline circuits.
4 Björk S et al. Quantitative determination of alpha2B-adrenoceptor-evoked myosin light chain phosphorylation in vascular smooth muscle cells.
5 Eerola K et al. Alpha-MSH overexpression in the nucleus tractus solitarius decreases fat mass and elevates heart rate.
6 Finnema SJ et al. Amphetamine decreases a2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
7 Halava H et al. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities.
8 Heinonen I et al. Myocardial blood flow and its transit time, oxygen utilization, and efficiency of highly endurance-trained human heart.
9 Heinonen I et al. The effects of equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular endothelial function in mice.
10 Heinonen I et al. Reply to "Letter to the editor: 'Deconstructing the dogma of sympathetic restraint and its role in the cardiovascular response to exercise'".
11 Helin-Salmivaara A et al. Sequential cohort design applying propensity score matching to analyze the comparative effectiveness of atorvastatin and simvastatin in preventing cardiovascular events.
12 Hokkanen AH et al. Sublingual administration of detomidine to calves prior to disbudding: a comparison with the intravenous route.
13 Hoppu U et al. Maternal dietary counseling reduces total and LDL cholesterol postpartum.
14 Huupponen R. Bakteerilääkkeet.
15 Huupponen R, Savontaus E. Diabetes, lihavuus ja metabolinen oireyhtymä.
16 Huupponen R, Savontaus E. Endokriiniseen järjestelmään vaikuttavat lääkeaineet .
17 Kauppila M et al. Myelodysplastinen oireyhtymä - monikasvoinen luuytimen toimintahäiriö.
18 Kontro M et al. Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.
19 Koskenvesa P et al. Imatinib and pegylated IFN-alfa2B discontinuation in first-line chronic myeloid leukemia patients following a major molecular response .
20 Kärpänoja P et al. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of viridans group streptococci.
21 Leinonen V et al. Diagnostic effectiveness of quantitative [18F]flutemetamol PET imaging for detection of fibrillar amyloid ß using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
22 Luoto P et al. 11C-ORM-13070, a novel PET ligand for brain a2c-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
23 Nuutila J et al. Bacterial infection (BI)-INDEX: an improved and simplified rapid flow cytometric bacterial infection marker.
24 Oksi J et al. Candida dubliniensis spondylodiscitis in an immunocompetent patient. Case report and review of the literature.
25 Pakkanen SA et al. Detomidine and the combination of detomidine and MK-467, a peripheral alpha-2 adrenoceptor antagonist, as premedication in horses anaesthetized with isoflurane.
26 Rikala M et al. Co-prescribing of potentially interacting drugs during warfarin therapy - A population-based register study.
27 Rinne JO et al. Prospective flutemetamol positron emission tomography and histopathology in normal pressure hydrocephalus.
28 Rinne P et al. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
29 Romppainen T et al. Measurement of statin exposure in the absence of information on prescribed doses.
30 Ruokoniemi P et al. Are statin trials in diabetes representative of real-world diabetes care: a population-based study on statin initiators in Finland.
31 Silvennoinen R et al. Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.
32 Snellman A et al. In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent (18F)flutemetamol.
33 Sulosaari V et al. Medication education in nursing programmes in Finland - Findings from a national survey.
34 Upmeier E et al. Older statin initiators in Finland - cardiovascular risk profiles and persistence of use.
35 Wasilewska A et al. Fluorinated analogues of marsanidine, a highly alpha2-AR/imidazoline I1 binding site-selective hypotensive agent. Synthesis and biological activities.
36 Zhang L et al. Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons.
Julkaisutietokanta 6.10.2015 Publications Data Base 6.10.2015